Literature DB >> 26549777

RADBIOMOD: A simple program for utilising biological modelling in radiotherapy plan evaluation.

Joe H Chang1, Christopher Gehrke2, Ramachandran Prabhakar2, Suki Gill2, Morikatsu Wada3, Daryl Lim Joon4, Vincent Khoo5.   

Abstract

PURPOSE: Radiotherapy plan evaluation is currently performed by assessing physical parameters, which has many limitations. Biological modelling can potentially allow plan evaluation that is more reflective of clinical outcomes, however further research is required into this field before it can be used clinically.
METHODS: A simple program, RADBIOMOD, has been developed using Visual Basic for Applications (VBA) for Microsoft Excel that incorporates multiple different biological models for radiotherapy plan evaluation, including modified Poisson tumour control probability (TCP), modified Zaider-Minerbo TCP, Lyman-Kutcher-Burman normal tissue complication probability (NTCP), equivalent uniform dose (EUD), EUD-based TCP, EUD-based NTCP, and uncomplicated tumour control probability (UTCP). RADBIOMOD was compared to existing biological modelling calculators for 15 sample cases.
RESULTS: Comparing RADBIOMOD to the existing biological modelling calculators, all models tested had mean absolute errors and root mean square errors less than 1%.
CONCLUSIONS: RADBIOMOD produces results that are non-significantly different from existing biological modelling calculators for the models tested. It is hoped that this freely available, user-friendly program will aid future research into biological modelling.
Copyright © 2015 Associazione Italiana di Fisica Medica. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biological modelling; Normal tissue complication probability; Radiotherapy plan evaluation; Tumour control probability

Mesh:

Substances:

Year:  2015        PMID: 26549777     DOI: 10.1016/j.ejmp.2015.10.091

Source DB:  PubMed          Journal:  Phys Med        ISSN: 1120-1797            Impact factor:   2.685


  8 in total

1.  Comparison of a Hybrid IMRT/VMAT technique with non-coplanar VMAT and non-coplanar IMRT for unresectable olfactory neuroblastoma using the RayStation treatment planning system-EUD, NTCP and planning study.

Authors:  Vijay P Raturi; Atsushi Motegi; Sadamoto Zenda; Naoki Nakamura; Hidehiro Hojo; Shin-Ichiro Kageyama; Masayuki Okumura; Toshiya Rachi; Hajime Ohyoshi; Hidenobu Tachibana; Kana Motegi; Takaki Ariji; Masaki Nakamura; Yasuhiro Hirano; Hidenari Hirata; Tetsuo Akimoto
Journal:  J Radiat Res       Date:  2021-05-12       Impact factor: 2.724

2.  Radiobiological model-based approach to determine the potential of dose-escalated robust intensity-modulated proton radiotherapy in reducing gastrointestinal toxicity in the treatment of locally advanced unresectable pancreatic cancer of the head.

Authors:  Vijay P Raturi; Hidehiro Hojo; Kenji Hotta; Hiromi Baba; Ryo Takahashi; Toshiya Rachi; Naoki Nakamura; Sadamoto Zenda; Atsushi Motegi; Hidenobu Tachibana; Takaki Ariji; Kana Motegi; Masaki Nakamura; Masayuki Okumura; Yasuhiro Hirano; Tetsuo Akimoto
Journal:  Radiat Oncol       Date:  2020-06-22       Impact factor: 3.481

3.  The Ever-Changing Role of Medical Physicists in the Era of Personalized Medicine.

Authors:  Loredana G Marcu
Journal:  J Med Phys       Date:  2021-02-02

4.  Simultaneous integrated boost (SIB) to dominant intra-prostatic lesions during extreme hypofractionation for prostate cancer: the impact of rectal spacers.

Authors:  Sarah O S Osman; Ciaran Fairmichael; Glenn Whitten; Gavin S Lundy; Rachel Wesselman; Melissa LaBonte Wilson; Alan R Hounsell; Kevin M Prise; Denise Irvine; Conor K McGarry; Suneil Jain
Journal:  Radiat Oncol       Date:  2022-02-22       Impact factor: 3.481

5.  Dose-escalated radiotherapy to 82 Gy for prostate cancer following insertion of a peri-rectal hydrogel spacer: 3-year outcomes from a phase II trial.

Authors:  Andrew W See; Patrick Bowden; Geoffrey Wells; Sree Appu; Nathan Lawrentschuk; Peter Liodakis; Chloe Pandeli; Yolanda Aarons; Lloyd M L Smyth; Dean P McKenzie
Journal:  Radiat Oncol       Date:  2022-07-25       Impact factor: 4.309

6.  Evaluation of Dose-Painting in the Dominant Intraprostatic Lesions by Radiobiological Parameters using 68Ga- PSMA PET/CT.

Authors:  Khadijeh Bamneshin; Seied Rabi Mahdavi; Ahmad Bitarafan-Rajabi; Parham Geramifar; Payman Hejazi; Fereshteh Koosha; Majid Jadidi
Journal:  J Biomed Phys Eng       Date:  2022-08-01

7.  Dose-Volume and Radiobiological Model-Based Comparative Evaluation of the Gastrointestinal Toxicity Risk of Photon and Proton Irradiation Plans in Localized Pancreatic Cancer Without Distant Metastasis.

Authors:  Vijay P Raturi; Taku Tochinai; Hidehiro Hojo; Toshiya Rachi; Kenji Hotta; Naoki Nakamura; Sadamoto Zenda; Atsushi Motegi; Takaki Ariji; Yasuhiro Hirano; Hiromi Baba; Hajime Ohyoshi; Masaki Nakamura; Masayuki Okumura; Yanping Bei; Tetsuo Akimoto
Journal:  Front Oncol       Date:  2020-10-23       Impact factor: 6.244

8.  Benefits of intraoral stents for sparing normal tissue in radiotherapy of nasopharyngeal carcinoma: a radiobiological model-based quantitative analysis.

Authors:  Zhen Hou; Shuangshuang Li; Yuya Jiang; Fangfang Sun; Juan Liu; Shanbao Gao; Weitao Chen; Jing Yan
Journal:  Transl Cancer Res       Date:  2021-10       Impact factor: 1.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.